Form 4 for PRU Prudential Financial
Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-08 · accession 0001127602-22-004330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-10 | 2022-02-08 | PRU | SULLIVAN ANDREW F | EVP | M - OptEx | $64.78 | +27.4K | 22.3K | New | +$1.78M |
| DM | 2022-02-10 | 2022-02-08 | PRU | SULLIVAN ANDREW F | EVP | S - Sale+OE | $121.47 | -18.3K | 8,096 | -69% | -$2.23M |
| D | 2022-02-10 | 2022-02-08 | PRU | SULLIVAN ANDREW F | EVP | F - Tax | $121.33 | -3,439 | 18.9K | -15% | -$417.3K |
| DM | 2022-02-10 | 2022-02-08 | PRU | SULLIVAN ANDREW F | EVP | M - OptEx | $0.00 | -23.5K | 0 | -100% | $0 |
| DM | 2022-02-10 | 2022-02-08 | PRU | SULLIVAN ANDREW F | EVP | A - Grant | $0.00 | +36.3K | 27.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-08 | M | A | 826 | $78.08 | 14,696 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-08 | M | A | 12,387 | $95.87 | 25,590 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-08 | S | D | 11,720 | $121.44 | 13,870 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.40 to $121.49 inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. |
| 4 | Common | Common Stock | 2022-02-08 | M | A | 4,681 | $93.36 | 13,870 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-08 | F | D | 3,439 | $121.33 | 18,863 | D | — | — | (F5) Represents shares withheld for the payment of taxes. |
| 6 | Common | Common Stock | 2022-02-08 | M | A | 749 | $77.15 | 9,189 | D | — | — | |
| 7 | Common | Common Stock | 2022-02-08 | M | A | 344 | $85.46 | 8,440 | D | — | — | |
| 8 | Common | Common Stock | 2022-02-08 | S | D | 6,600 | $121.52 | 8,096 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.49 to $121.52 inclusive. The reporting person undertakes to provide to Prudential Financial, Inc., any security holder of Prudential Financial, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. |
| 9 | Common | Common Stock | 2022-02-08 | M | A | 8,432 | $0.00 | 22,302 | D | — | — | (F4) Includes cash settled performance units which were converted from cash to equity settlement based on a decision by the Compensation Committee. (F3) The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. |
| 10 | Derivative | 10/13/15 Employee Stock Option (Right to Buy) | 2022-02-08 | M | D | 749 | $0.00 | 0 | D | $77.15 · — to 2025-10-13 | 749 Common Stock | (F10) The options vest in three equal annual installments beginning on October 13, 2016. |
| 11 | Derivative | 2020 Employee Stock Option (Right to Buy) | 2022-02-08 | M | D | 12,387 | $0.00 | 24,776 | D | $95.87 · — to 2030-02-11 | 12,387 Common Stock | (F7) The options vest in three equal annual installments beginning on February 11, 2021. |
| 12 | Derivative | 2019 Employee Stock Option (Right to Buy) | 2022-02-08 | M | D | 4,681 | $0.00 | 2,341 | D | $93.36 · — to 2029-02-12 | 4,681 Common Stock | (F8) The options vest in three equal annual installments beginning on February 12, 2020. |
| 13 | Derivative | 2015 Employee Stock Option (Right to Buy) | 2022-02-08 | M | D | 826 | $0.00 | 0 | D | $78.08 · — to 2025-02-10 | 826 Common Stock | (F9) The options vest in three equal annual installments beginning February 10, 2016. |
| 14 | Derivative | 2019 Performance Shares | 2022-02-08 | M | D | 4,499 | $0.00 | 0 | D | $0.00 · — to — | 4,499 Common Stock | (F3) The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2019 through 2021 performance period. |
| 15 | Derivative | 5/15/15 Employee Stock Option (Right to Buy) | 2022-02-08 | M | D | 344 | $0.00 | 0 | D | $85.46 · — to 2025-05-15 | 344 Common Stock | (F11) The options vest in three equal annual installments beginning on May 15, 2016. |
| 16 | Derivative | 2022 Restricted Stock Units | 2022-02-08 | A | A | 9,067 | $0.00 | 9,067 | D | $0.00 · — to — | 9,067 Common Stock | (F12) The Restricted Stock Units convert to common stock on a 1 to 1 basis. (F13) The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023. |
| 17 | Derivative | 2022 Performance Shares | 2022-02-08 | A | A | 27,199 | $0.00 | 27,199 | D | $0.00 · — to — | 27,199 Common Stock | (F14) The performance shares convert to common stock on a 1 to 1 basis. (F15) Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period. |